Exela Technologies Inc
NASDAQ:XELA

Watchlist Manager
Exela Technologies Inc Logo
Exela Technologies Inc
NASDAQ:XELA
Watchlist
Price: 0.05 USD
Market Cap: $1.4m

Exela Technologies Inc
Investor Relations

Exela Technologies, Inc. engages in the provision of transaction processing solutions and enterprise information management. The company is headquartered in Irving, Texas and currently employs 17,000 full-time employees. The company went IPO on 2015-01-16. Exela’s segments include Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS) and Legal & Loss Prevention Services (LLPS). ITPS provides a range of solutions and services designed to aid businesses in information capture, processing, decisioning and distribution to customers primarily in the financial services, commercial, public sector and legal industries. HS operates and maintains a consulting and outsourcing business specializing in both the healthcare provider and payer markets. LLPS segment provides support services, such as bankruptcy labor, claims adjudication and employment and other legal matters. The Company’s technology-enabled solutions allow global organizations to address critical challenges.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Nov 29, 2024
AI Summary
Q3 2024

Revenue Growth: Exela reported Q3 revenue of $269.2 million, up 6.3% year-over-year.

Gross Margin Pressure: Gross margin fell to 20.2%, down 330 basis points sequentially and 140 basis points year-over-year due to higher postage costs.

Segment Performance: ITPS grew significantly while Healthcare Solutions and LLPS segments declined year-over-year.

Cost Actions: SG&A expenses decreased both year-over-year and sequentially, driven by cost-cutting initiatives.

Net Loss Narrows: Net loss improved by $2 million sequentially to $24.9 million.

NASDAQ Delisting: Exela was delisted from NASDAQ due to market cap, but management says operations are unaffected.

Key Financials
Revenue
$269.2 million
Gross Margin
20.2%
Net Loss
$24.9 million
Adjusted EBITDA
$14.6 million
Cash Flow from Operations
$5 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Parvinder S. Chadha
Executive Chairman
No Bio Available
Mr. Matthew T. Brown
Interim CFO & President of ETI-MNA
No Bio Available
Mr. Suresh Yannamani
Chief Executive Officer of Exela BPA
No Bio Available
Mr. Sriram Ramanathan
Chief Technology Officer
No Bio Available
Mr. Erik L. Mengwall
Deputy General Counsel & Secretary
No Bio Available
Vincent Kondaveeti
Vice President of Corporate Development
No Bio Available
Mr. Carlos Mallen
Senior Vice President of Human Resources for Americas & EMEA
No Bio Available
Mr. Srinivasan Murali
President of Americas & APAC at Exela Technologies
No Bio Available
Mr. Sanjay Kulkarni
President of Digital Assets
No Bio Available
Mr. Eokesh Natarajan
President of Payer Operations - Exela Healthcare Solutions
No Bio Available

Contacts

Address
TEXAS
Irving
2701 E Grauwyler Rd
Contacts
+18449352832.0
www.exelatech.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett